Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, today announced the publication of a prospective real-world study demonstrating that its AI imaging ...

FDA has granted orphan drug designation to FS2 (kynurenic acid) for the investigational treatment of idiopathic pulmonary ...

Dr. Barnard explains how his research suggests that processed meat may negatively affect not only your heart health, but also ...

Columnist Samuel Kirton shares his emergency "go bag" checklist of things he brought when he received a bilateral lung ...

Chronic conditions and rare diseases in the aging population present an urgent and expanding challenge within the U.S. healthcare system, especially ...

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...

BirchBioMed Inc., a leading clinical stage biopharmaceutical company, expert in the development of products for scarring and other fibrosis-related disorders and autoimmune therapeutics, today ...

New research out of the University of Iowa is reshaping what it means to live with cystic fibrosis, a genetic disease that ...